Molecular Targets and Pathways
Molecular Targets and Pathways Technological advances have paved the way for a precision treatment tailored to both patient and tumor. DNA is the key to targeted anti-cancer therapies. We want…
Targeted and Immunotherapy Agents
Targeted and Immunotherapy Agents Color Key Agents in early-stage clinical trial investigations first in man, phase 1 Agents in late-stage clinical trial investigations (phases 2 and 3) FDA-approved agents FDA-approved…
Carcinogenesis from the Perspective of Targeted Therapy and Immunotherapy
Carcinogenesis from the Perspective of Targeted Therapy and Immunotherapy Introduction In this section, we will discuss elements of cellular biology and immunology that have given insight into personalized genomically based…
Targets by Organ Site
Targets by Organ Site Abbreviations • CBR: clinical benefit rate (CR + PR + SD) • CR: complete response • d: days • DOR: duration of response • HR: heart…
